Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Exemestane in Post-Menopausal Women With NSCLC

ClinicalTrials.gov ID: NCT02666105

Public ClinicalTrials.gov record NCT02666105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Exemestane in Previously Treated Post-Menopausal Women With Advanced Non-Small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase II therapeutic study of adding exemestane therapy in post-menopausal women with advanced non-small cell lung cancer (NSCLC) who are progressing while on treatment with an immune checkpoint antibody (pembrolizumab, atezolizumab, or nivolumab).

Study identification

NCT ID
NCT02666105
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
6 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2018 (Actual)
Primary completion
Feb 28, 2022 (Actual)
Completion
Feb 28, 2022 (Actual)
Last update posted
May 31, 2023

2018 – 2022

United States locations

U.S. sites
18
U.S. states
1
U.S. cities
17
Facility City State ZIP Site status
Mayo Clinic Health System Albert Lea Minnesota 56007 —
Essentia Health St. Joseph's Medical Center Brainerd Minnesota 56401 —
Essentia Health Deer River Deer River Minnesota 56636 —
Essentia Health St. Mary's Detroit Lakes Detroit Lakes Minnesota 56501 —
Essentia Health Cancer Center Duluth Minnesota 55805 —
Essentia Health Fosston Fosston Minnesota 56542 —
Fairview Grand Itasca Clinic & Hospital Grand Rapids Minnesota 55744 —
Essentia Health Hibbing Hibbing Minnesota 55746 —
Fairview Range Medical Center Hibbing Minnesota 55746 —
Mayo Clinic Health System Mankato Minnesota 56001 —
Masonic Cancer Center, University of Minnesota Minneapolis Minnesota 55455 —
Monticello Cancer Center (MMCORC) Monticello Minnesota 55362 —
Essentia Health Park Rapids Park Rapids Minnesota 56470 —
Fairview Northland Medical Center Princeton Minnesota 55731 —
Essentia Health Sandstone Sandstone Minnesota 55072 —
Sanford Thief River Falls Medical Center Thief River Falls Minnesota 56701 —
Essentia Health Virginia Virginia Minnesota 55792 —
Sanford Worthington Medical Center Worthington Minnesota 56187 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02666105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02666105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →